BIEI (Premier Biomedical) DeferredTaxAndRevenue: $0.00 Mil (As of Dec. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Premier Biomedical DeferredTaxAndRevenue?

Premier Biomedical BIEI +4.48% DeferredTaxAndRevenue is $0.00 Mil as of Dec. 2019.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Premier Biomedical's current deferred tax and revenue for the quarter that ended in Dec. 2019 was $0.00 Mil.

Premier Biomedical DeferredTaxAndRevenue Related Terms

Premier Biomedical DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Premier Biomedical's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Premier Biomedical DeferredTaxAndRevenue Chart

Premier Biomedical Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Premier Biomedical Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.00 Mil mean?
Premier Biomedical (BIEI) has a DeferredTaxAndRevenue of $0.00 Mil as of Dec. 2019. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Premier Biomedical.
Is Premier Biomedical's DeferredTaxAndRevenue too high?
Premier Biomedical's current DeferredTaxAndRevenue is $0.00 Mil.
How does Premier Biomedical's DeferredTaxAndRevenue compare to PTXTQ and STNN?
Premier Biomedical's DeferredTaxAndRevenue of $0.00 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Chemicals company?
A good DeferredTaxAndRevenue depends on the Chemicals industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Premier Biomedical. Premier Biomedical's current DeferredTaxAndRevenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Premier Biomedical stock overvalued right now?
Premier Biomedical (BIEI) has a current DeferredTaxAndRevenue of $0.00 Mil. The current DeferredTaxAndRevenue is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Premier Biomedical (BIEI), the current DeferredTaxAndRevenue is $0.00 Mil as of Dec. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Premier Biomedical Business Description

Address 1150 S. 8th Street, El Centro, CA, USA, 92243
Premier Biomedical Inc is engaged in a hemp based initiative, developing graphene enhanced formulations for a myriad of commercial and military applications and complementing new EV battery technology.